WC
NTUS

Walthausen & Co’s Natus Medical Inc NTUS Stock Holding History

Walthausen & Co’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-62,760
Closed -$1.37M – 141
2020
Q2 		$1.37M Sell
62,760
-36,520
-37% -$836K 0.28% 104
2020
Q1 		$2.3M Sell
99,280
-2,400
-2% -$69.8K 0.49% 84
2019
Q4 		$3.35M Buy
101,680
+40,247
+66% +$1.29M 0.44% 85
2019
Q3 		$1.96M Buy
+61,433
New +$1.79M 0.27% 95

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walthausen & Co's NTUS Position: Q3 2020 in Review

Walthausen & Co sold out of Natus Medical Inc (NTUS) in Q3 2020, closing a stake of 62,760 shares — an estimated $1.37M sold.

Walthausen & Co first reported a position in NTUS in Q3 2019 and held it in 4 quarters. The position peaked at $3.35M in Q4 2019. 159 funds tracked by Wall St. Rank hold NTUS as of Q3 2020.

  • Walthausen & Co reported no remaining Natus Medical Inc position as of Q3 2020 after selling out during the quarter.
  • Walthausen & Co sold 62,760 Natus Medical Inc shares in Q3 2020, an estimated $1.37M.
  • Walthausen & Co first reported a position in Natus Medical Inc in Q3 2019 and held it in 4 quarters.
  • Walthausen & Co's Natus Medical Inc position peaked at $3.35M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2020.

Based on Walthausen & Co's 13F filing for Q3 2020, filed 12 Nov 2020.